These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 9419621)

  • 1. Effect of arterial cannulation and contrast agents on blood coagulation.
    Cousins C; Dutka DP; Bradshaw A; Dawson P
    Acad Radiol; 1995 Aug; 2(8):663-6. PubMed ID: 9419621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The clotting issue: etiologic factors in thromboembolism. II. Clinical considerations.
    Dawson P; Cousins C; Bradshaw A
    Invest Radiol; 1993 Nov; 28 Suppl 5():S31-6; discussion S37-8. PubMed ID: 8282500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparative thrombotic risk of two contrast agents in coronary angiography].
    Wolff F; Zupan M; Klero de Rosbo P; Wiesel ML; Grunebaum L; Cazenave JP; Brechenmacher C
    Ann Radiol (Paris); 1994; 37(6):435-9. PubMed ID: 7702336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of the markers of platelet and coagulation activation following transcatheter closure of atrial septal defects.
    Rodés-Cabau J; Palacios A; Palacio C; Girona J; Galve E; Evangelista A; Casaldáliga J; Albert D; Picó M; Soler-Soler J
    Int J Cardiol; 2005 Jan; 98(1):107-12. PubMed ID: 15676174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased left atrial thrombin generation in mitral stenosis is not reflected in arterial prothrombin fragment 1+2 levels.
    Peverill RE; Harper RW; Gan TE; Smolich JJ
    Clin Sci (Lond); 2000 Apr; 98(4):501-6. PubMed ID: 10731487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The favorable effect of regional citrate anticoagulation on interleukin-1beta release is dissociated from both coagulation and complement activation.
    Gabutti L; Ferrari N; Mombelli G; Keller F; Marone C
    J Nephrol; 2004; 17(6):819-25. PubMed ID: 15593057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coagulation and fibrinolytic markers in a two-month follow-up of coronary bypass surgery.
    Parolari A; Colli S; Mussoni L; Eligini S; Naliato M; Wang X; Gandini S; Tremoli E; Biglioli P; Alamanni F
    J Thorac Cardiovasc Surg; 2003 Feb; 125(2):336-43. PubMed ID: 12579103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effects of uro-angiographic contrast media on blood coagulation--a scanning electron microscopic study on time dependent changes of blood clot and a clinical study].
    Himi K; Himi S; Takemoto A; Kamata R
    Nihon Igaku Hoshasen Gakkai Zasshi; 1992 Jan; 52(1):52-61. PubMed ID: 1549448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prothrombin fragment 1+2 in urine as an indicator of sustained coagulation activation after total hip arthroplasty.
    Borris LC; Breindahl M; Ryge C; Sommer HM; Lassen MR;
    Thromb Res; 2007; 121(3):369-76. PubMed ID: 17599394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of quality and timing of venepuncture on markers of blood coagulation in healthy middle-aged men.
    Miller GJ; Bauer KA; Barzegar S; Foley AJ; Mitchell JP; Cooper JA; Rosenberg RD
    Thromb Haemost; 1995 Jan; 73(1):82-6. PubMed ID: 7740501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thromboelastographic changes following nonionic contrast medium injection during transfemoral angiography in patients with peripheral arterial occlusive disease.
    Shankar VK; Handa A; Philips-Hughes J; Boardman P; Uberoi R; Hands LJ
    Cardiovasc Intervent Radiol; 2006; 29(6):1046-52. PubMed ID: 16810462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical evaluation of SyvekPatch in patients undergoing interventional, EPS and diagnostic cardiac catheterization procedures.
    Nader RG; Garcia JC; Drushal K; Pesek T
    J Invasive Cardiol; 2002 Jun; 14(6):305-7. PubMed ID: 12042620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma protein oxidation is associated with an increase of procoagulant markers causing an imbalance between pro- and anticoagulant pathways in healthy subjects.
    De CR; Rocca B; Marchioli R; Landolfi R
    Thromb Haemost; 2002 Jan; 87(1):58-67. PubMed ID: 11848457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Levels of prothrombin activation peptide F1+2 in patients with a bleeding tendency.
    Ingerslev J; Holm M; Christiansen K; Knudsen L; Négrier C
    Blood Coagul Fibrinolysis; 1998 Mar; 9 Suppl 1():S129-34. PubMed ID: 9819044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Factors determining late patency of aortobifemoral bypass graft].
    Davidović LB; Lotina SI; Kostić DM; Cinara II; Cvetković SD; Stojanov PL; Velimirović DB; Marković MM; Pejkić SA; Vukotić AM
    Srp Arh Celok Lek; 1997; 125(1-2):24-35. PubMed ID: 17974352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coagulation and fibrinolysis are in balance after moderate exercise in middle-aged participants.
    Menzel K; Hilberg T
    Clin Appl Thromb Hemost; 2009; 15(3):348-55. PubMed ID: 19022797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of prothrombin complex concentrate on INR and blood coagulation system in emergency patients treated with warfarin overdose.
    Yasaka M; Oomura M; Ikeno K; Naritomi H; Minematsu K
    Ann Hematol; 2003 Feb; 82(2):121-3. PubMed ID: 12601493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of coagulation during hemodialysis: effect of blood lines alone and whole extracorporeal circuit.
    Lucchi L; Ligabue G; Marietta M; Delnevo A; Malagoli M; Perrone S; Stipo L; Grandi F; Albertazzi A
    Artif Organs; 2006 Feb; 30(2):106-10. PubMed ID: 16433843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Complications of continuous intra-arterial infusion in patients with occlusive vascular diseases].
    Rudush VE
    Vestn Khir Im I I Grek; 1988 Mar; 140(3):93-4. PubMed ID: 3407092
    [No Abstract]   [Full Text] [Related]  

  • 20. Reactivation of coagulation after stopping infusions of recombinant hirudin and unfractionated heparin in unstable angina and myocardial infarction without ST elevation: results of a randomized trial. OASIS Pilot Study Investigators. Organization to Assess Strategies for Ischemic++ Syndromes.
    Flather MD; Weitz JI; Yusuf S; Pogue J; Sussex B; Campeau J; Gill J; Schuld R; Joyner CD; Morris AL; Lai C; Théroux P; Marquis JF; Chan YK; Venkatesh G; Jessel A
    Eur Heart J; 2000 Sep; 21(17):1473-81. PubMed ID: 10952840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.